We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROO icon
8676
TROOPS Inc
TROO
$238M
$15K ﹤0.01%
+17,342
New +$16.7K
MTVA
8677
MetaVia Inc
MTVA
$7.75M
0
NTBL
8678
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$15K ﹤0.01%
451
-83
-16% -$3.66K
NURO
8679
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$15K ﹤0.01%
+253
New +$21.1K
INFI
8680
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$15K ﹤0.01%
12,300
-30,600
-71% -$55K
NH
8681
DELISTED
NantHealth, Inc
NH
$15K ﹤0.01%
1,790
+1,059
+145% +$18.6K
AXU
8682
CALL
DELISTED
Alexco Resource Corp
AXU
$15K ﹤0.01%
+16,300
New +$14.7K
VLRX
8683
DELISTED
VALERITAS HOLDINGS INC
VLRX
$15K ﹤0.01%
+2,304
New +$37K
MLNT
8684
CALL
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$15K ﹤0.01%
+3,740
New +$47.8K
PTX
8685
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$15K ﹤0.01%
+36,554
New +$22.7K
OHAI
8686
DELISTED
OHA Investment Corporation
OHAI
$15K ﹤0.01%
14,706
+3,503
+31% +$4.57K
ABTS icon
8687
Abits Group
ABTS
$3.88M
$14K ﹤0.01%
544
+247
+83% +$10.8K
ALTO icon
8688
PUT
Alto Ingredients
ALTO
$325M
$14K ﹤0.01%
16,200
-31,900
-66% -$52.7K
CAPR icon
8689
Capricor Therapeutics
CAPR
$373M
$14K ﹤0.01%
3,305
+1,658
+101% +$13.2K
DSS icon
8690
DSS Inc
DSS
$5.68M
$14K ﹤0.01%
+35
New +$18.7K
KOPN icon
8691
PUT
Kopin
KOPN
$991M
$14K ﹤0.01%
14,500
-1,600
-10% -$2.88K
NNVC icon
8692
NanoViricides
NNVC
$34.9M
$14K ﹤0.01%
3,472
+1,214
+54% +$7.78K
SISI
8693
DELISTED
Shineco
SISI
0
TENX icon
8694
Tenax Therapeutics
TENX
$68.1M
$14K ﹤0.01%
+7
New +$38.5K
TRX icon
8695
TRX Gold Corp
TRX
$363M
$14K ﹤0.01%
39,022
-13,367
-26% -$5.03K
WRN
8696
Western Copper and Gold
WRN
$543M
$14K ﹤0.01%
+30,053
New +$17.2K
LGC.WS
8697
DELISTED
Legacy Acquisition Corp. Warrants, exercisable for one-half of one share of Class A Common Stock for
LGC.WS
$14K ﹤0.01%
42,147
+5,312
+14% +$2.06K
DYSL
8698
DELISTED
Dynasil Corporation of America
DYSL
$14K ﹤0.01%
15,626
+863
+6% +$901
EMITF
8699
DELISTED
Elbit Imaging Ltd
EMITF
$14K ﹤0.01%
11,124
-18,551
-63% -$34.5K
OHGI
8700
DELISTED
One Horizon Group, Inc.
OHGI
$14K ﹤0.01%
156,939
+142,945
+1,021% +$25.8K

Similar funds

Citadel Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Citadel Advisors held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Assurant worth $99.4M.

  • Citadel Advisors's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Citadel Advisors added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Citadel Advisors's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Citadel Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Citadel Advisors's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Citadel Advisors opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Citadel Advisors's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.